Selective ET_AR antagonist atrasentan inhibits hypoxia-induced breast cancer cell invasion

Medicine and Dentistry

• Breast Cancer 100%
• Cancer Cell 100%
• Cell Invasion 100%
• Atrasentan 100%
• Endothelin 1 75%
• Endothelin 62%
• Metastatic Carcinoma 25%
• Breast Carcinoma 25%
• Tumor Hypoxia 25%
• Immunohistochemistry 12%
• In Vitro 12%
• Receptor 12%
• Solid Malignant Neoplasm 12%
• Cancer Tissue 12%
• MCF-7 12%
• Secretion (Process) 12%

Biochemistry, Genetics and Molecular Biology

• Hypoxia Inducible Factor 1 100%
• Cancer Cell 100%
• Cell Invasion 100%
• Endothelin 83%
• Tumor Hypoxia 33%
• Secretion (Process) 16%
• Real-Time Polymerase Chain Reaction 16%
• Transcription 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Hypoxia 100%
• Breast Cancer 100%
• Endothelin 62%
• Neoplasm 25%
• Breast Carcinoma 25%
• Receptor 12%
• Solid Malignant Neoplasm 12%